Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 10 | 2022 | 1092 | 3.040 |
Why?
|
| Genomics | 6 | 2022 | 293 | 2.340 |
Why?
|
| Neoplasms | 6 | 2023 | 1377 | 1.580 |
Why?
|
| Computational Biology | 6 | 2021 | 327 | 1.500 |
Why?
|
| Mutation | 6 | 2022 | 1177 | 1.320 |
Why?
|
| Prostate-Specific Antigen | 2 | 2021 | 147 | 1.290 |
Why?
|
| Software | 2 | 2019 | 236 | 1.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2020 | 968 | 1.000 |
Why?
|
| Gene Regulatory Networks | 4 | 2022 | 149 | 0.960 |
Why?
|
| RNA, Messenger | 4 | 2016 | 1271 | 0.960 |
Why?
|
| Genes, Neoplasm | 2 | 2018 | 14 | 0.920 |
Why?
|
| Gene Expression Profiling | 5 | 2020 | 704 | 0.910 |
Why?
|
| MicroRNAs | 3 | 2016 | 518 | 0.790 |
Why?
|
| Signal Transduction | 6 | 2021 | 2157 | 0.770 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 423 | 0.760 |
Why?
|
| SEER Program | 2 | 2020 | 164 | 0.740 |
Why?
|
| Lymphocytes | 2 | 2013 | 124 | 0.740 |
Why?
|
| Humans | 30 | 2023 | 43102 | 0.720 |
Why?
|
| Mibefradil | 1 | 2021 | 2 | 0.700 |
Why?
|
| Calcium Channels, T-Type | 1 | 2021 | 4 | 0.700 |
Why?
|
| Prognosis | 6 | 2022 | 861 | 0.700 |
Why?
|
| Cyclopropanes | 1 | 2021 | 46 | 0.690 |
Why?
|
| Naphthalenes | 1 | 2021 | 38 | 0.690 |
Why?
|
| Calcium Channel Blockers | 1 | 2021 | 55 | 0.680 |
Why?
|
| Drug Interactions | 1 | 2021 | 150 | 0.680 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 863 | 0.680 |
Why?
|
| Benzimidazoles | 1 | 2021 | 43 | 0.680 |
Why?
|
| Ovarian Neoplasms | 2 | 2016 | 415 | 0.670 |
Why?
|
| Drug Discovery | 1 | 2021 | 108 | 0.650 |
Why?
|
| DNA Mutational Analysis | 2 | 2018 | 95 | 0.650 |
Why?
|
| Models, Genetic | 2 | 2018 | 183 | 0.640 |
Why?
|
| Alu Elements | 2 | 2011 | 12 | 0.640 |
Why?
|
| Cluster Analysis | 5 | 2020 | 207 | 0.620 |
Why?
|
| Herpesvirus 4, Human | 2 | 2016 | 36 | 0.610 |
Why?
|
| Tobacco Use Disorder | 1 | 2023 | 250 | 0.610 |
Why?
|
| Protein Interaction Mapping | 1 | 2019 | 65 | 0.600 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2019 | 267 | 0.600 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2022 | 220 | 0.580 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2018 | 61 | 0.570 |
Why?
|
| Gene Silencing | 1 | 2018 | 154 | 0.540 |
Why?
|
| Models, Molecular | 1 | 2021 | 876 | 0.530 |
Why?
|
| Tuberculosis | 1 | 2018 | 78 | 0.530 |
Why?
|
| Genome, Human | 3 | 2014 | 144 | 0.520 |
Why?
|
| Host-Pathogen Interactions | 2 | 2018 | 209 | 0.520 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2018 | 109 | 0.510 |
Why?
|
| Databases, Nucleic Acid | 1 | 2016 | 30 | 0.500 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2016 | 20 | 0.490 |
Why?
|
| Sequence Analysis, RNA | 2 | 2013 | 115 | 0.480 |
Why?
|
| Exons | 2 | 2013 | 92 | 0.480 |
Why?
|
| Smoking Cessation | 1 | 2023 | 590 | 0.480 |
Why?
|
| Models, Statistical | 2 | 2014 | 195 | 0.480 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 291 | 0.480 |
Why?
|
| Public Health | 1 | 2020 | 424 | 0.470 |
Why?
|
| Head and Neck Neoplasms | 1 | 2016 | 81 | 0.460 |
Why?
|
| DNA Methylation | 1 | 2018 | 403 | 0.440 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 186 | 0.430 |
Why?
|
| Computer Simulation | 1 | 2016 | 408 | 0.420 |
Why?
|
| Proteins | 1 | 2016 | 382 | 0.410 |
Why?
|
| Carcinoma | 1 | 2014 | 108 | 0.410 |
Why?
|
| DNA Transposable Elements | 1 | 2013 | 55 | 0.400 |
Why?
|
| Bacterial Proteins | 1 | 2018 | 595 | 0.400 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 228 | 0.380 |
Why?
|
| Carrier Proteins | 1 | 2014 | 321 | 0.380 |
Why?
|
| Survival Analysis | 3 | 2020 | 368 | 0.380 |
Why?
|
| Male | 10 | 2022 | 23409 | 0.370 |
Why?
|
| Papillomavirus Infections | 1 | 2016 | 376 | 0.350 |
Why?
|
| ROC Curve | 2 | 2021 | 159 | 0.310 |
Why?
|
| Algorithms | 4 | 2016 | 509 | 0.300 |
Why?
|
| Databases, Genetic | 2 | 2020 | 103 | 0.300 |
Why?
|
| Aged | 4 | 2023 | 8214 | 0.290 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 1070 | 0.250 |
Why?
|
| Incidence | 2 | 2020 | 1078 | 0.230 |
Why?
|
| Regression Analysis | 2 | 2020 | 490 | 0.220 |
Why?
|
| Aged, 80 and over | 2 | 2023 | 2853 | 0.220 |
Why?
|
| Logistic Models | 2 | 2018 | 1009 | 0.220 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 734 | 0.200 |
Why?
|
| Lysine | 1 | 2023 | 119 | 0.190 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1723 | 0.190 |
Why?
|
| Linear Models | 2 | 2013 | 317 | 0.190 |
Why?
|
| Neutrophils | 1 | 2023 | 145 | 0.180 |
Why?
|
| Middle Aged | 3 | 2023 | 12222 | 0.180 |
Why?
|
| Bayes Theorem | 1 | 2022 | 126 | 0.180 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 154 | 0.170 |
Why?
|
| Cell Line | 3 | 2015 | 1410 | 0.170 |
Why?
|
| Transcription, Genetic | 2 | 2015 | 592 | 0.170 |
Why?
|
| Germ Cells | 1 | 2021 | 74 | 0.170 |
Why?
|
| Nutrition Surveys | 1 | 2021 | 263 | 0.160 |
Why?
|
| Prostatectomy | 1 | 2020 | 70 | 0.160 |
Why?
|
| Demography | 1 | 2020 | 195 | 0.150 |
Why?
|
| CpG Islands | 1 | 2018 | 109 | 0.140 |
Why?
|
| Area Under Curve | 1 | 2018 | 95 | 0.140 |
Why?
|
| Immune System | 1 | 2018 | 41 | 0.140 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 1067 | 0.140 |
Why?
|
| Risk Assessment | 1 | 2021 | 863 | 0.140 |
Why?
|
| Registries | 1 | 2020 | 437 | 0.140 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2018 | 90 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1285 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 118 | 0.130 |
Why?
|
| Age Factors | 1 | 2020 | 1154 | 0.130 |
Why?
|
| Databases, Protein | 1 | 2016 | 54 | 0.130 |
Why?
|
| Interleukins | 1 | 2016 | 40 | 0.130 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2016 | 9 | 0.120 |
Why?
|
| Hyperinsulinism | 1 | 2016 | 17 | 0.120 |
Why?
|
| Prevalence | 1 | 2021 | 1612 | 0.120 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2016 | 29 | 0.120 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2016 | 81 | 0.120 |
Why?
|
| Interleukin-17 | 1 | 2016 | 53 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 1 | 2018 | 526 | 0.120 |
Why?
|
| Smoking | 1 | 2023 | 1024 | 0.120 |
Why?
|
| Receptors, Androgen | 1 | 2016 | 144 | 0.120 |
Why?
|
| Octamer Transcription Factors | 1 | 2015 | 1 | 0.120 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2015 | 4 | 0.120 |
Why?
|
| Atlases as Topic | 1 | 2014 | 7 | 0.110 |
Why?
|
| RNA, Untranslated | 1 | 2015 | 50 | 0.110 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 2015 | 113 | 0.110 |
Why?
|
| Expressed Sequence Tags | 1 | 2013 | 28 | 0.100 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 161 | 0.100 |
Why?
|
| Quantitative Trait Loci | 1 | 2013 | 88 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3156 | 0.100 |
Why?
|
| Virus Replication | 1 | 2015 | 318 | 0.100 |
Why?
|
| Linkage Disequilibrium | 1 | 2012 | 86 | 0.090 |
Why?
|
| Young Adult | 1 | 2023 | 5080 | 0.090 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 82 | 0.090 |
Why?
|
| Genes, Recessive | 1 | 2011 | 8 | 0.090 |
Why?
|
| Neoplasm Metastasis | 1 | 2012 | 237 | 0.080 |
Why?
|
| Introns | 1 | 2011 | 79 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2012 | 216 | 0.080 |
Why?
|
| Inflammation | 1 | 2016 | 758 | 0.080 |
Why?
|
| Gene Expression | 1 | 2013 | 701 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2010 | 141 | 0.080 |
Why?
|
| Binding Sites | 1 | 2012 | 671 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 310 | 0.080 |
Why?
|
| Genotype | 1 | 2012 | 800 | 0.070 |
Why?
|
| Pan troglodytes | 1 | 2009 | 20 | 0.070 |
Why?
|
| Data Mining | 1 | 2009 | 30 | 0.070 |
Why?
|
| Drosophila melanogaster | 1 | 2010 | 193 | 0.070 |
Why?
|
| Sequence Alignment | 1 | 2009 | 272 | 0.070 |
Why?
|
| Obesity | 1 | 2016 | 1151 | 0.070 |
Why?
|
| Female | 3 | 2016 | 24698 | 0.060 |
Why?
|
| Adult | 1 | 2023 | 13872 | 0.060 |
Why?
|
| Animals | 3 | 2016 | 16992 | 0.050 |
Why?
|
| Acetylation | 1 | 2023 | 107 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2023 | 118 | 0.050 |
Why?
|
| Catalysis | 1 | 2023 | 187 | 0.050 |
Why?
|
| Mice, Obese | 1 | 2016 | 42 | 0.030 |
Why?
|
| Replication Origin | 1 | 2015 | 16 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2016 | 140 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2015 | 171 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 986 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 1621 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 561 | 0.020 |
Why?
|
| Protein Binding | 1 | 2015 | 1082 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1455 | 0.020 |
Why?
|
| Apoptosis | 1 | 2016 | 1568 | 0.020 |
Why?
|
| Mice | 1 | 2016 | 6644 | 0.010 |
Why?
|